InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
-0.29%
)
US TECH 100
18,893.60
(
-0.24%
)
Dow Jones
41,503.10
(
-0.25%
)
Brent Oil
72.41
(
-1.24%
)
Bitcoin
60,364.25
(
0.11%
)
Post# of 197569
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

budfoxfun

Send PM Follow Ignore
Followers 972
Posts 383062
Boards Moderated 5
Alias Born 06/24/2011

budfoxfun

Re: None

Monday, 02/06/2017 12:51:57 PM

Monday, February 06, 2017 12:51:57 PM

Post# of 197569
$ENTB About Zander Therapeutics Inc.: Currently the Company is developing products treating blood disorders using small molecules based on NR2F6 under an exclusive license agreement for veterinary use from Regen BioPharma Inc. (OTCQB: RGBP), gene silencing for treating cancer with immunotherapy, modulating key molecular processes in cancer stem cell through its patent molecular targeting approaches and repairing damaged bone marrow in animals with aplastic anemia and bone marrow suppression due to side effects of chemotherapy/radiotherapy treated cancer patients.

http://www.zandertherapeutics.weebly.com/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up